Cancer immunotherapy and nanomedicine. - Wikidata - wikimedia - TriplyDB

Cancer immunotherapy and nanomedicine.

Cancer immunotherapy and nanomedicine.

http://www.wikidata.org/entity/Q37785836

about

Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach Cell delivery of therapeutic nanoparticles Convergence of nanotechnology and cancer prevention: are we there yet?Nano polymeric carrier fabrication technologies for advanced antitumor therapy Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors Shedding light on nanomedicine.Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?Nanocarrier-based immunotherapy in cancer management and research.Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS).Bioceramics: from bone regeneration to cancer nanomedicine.A comparison inhibitory effects of cisplatin and MNPs-PEG-cisplatin on the adhesion capacity of bone metastatic breast cancer.Emerging nanotechnologies for cancer immunotherapy Application of nanostructured drug delivery systems in immunotherapy of cancer: a review.Immunoengineering with biomaterials for enhanced cancer immunotherapy.A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.

P2860

Q26996790-1EEA59C5-4C15-4841-ACA4-9704058A0B81 Q28385606-56C2891A-8260-4D1D-90B4-C5253F0842C4 Q28386699-87447C7B-7A05-429B-890B-4A82290B280A Q28393168-E9B8C50E-DD46-439C-87C1-F46ED780650A Q28484683-0363A93C-1F5B-4990-8D60-65D443ACC7F7 Q30447871-B5C0C641-6B20-466A-948F-D6BFC1A924FC Q36170378-8EBBE1BA-CF37-407F-939E-C8123E77513F Q37029367-0169D67D-034E-4247-A830-752B6C4749CC Q37031671-40F9A044-74FD-4ACB-B4DA-3F262DD074FC Q37731681-48499800-57A4-481F-9063-E05F208AA789 Q37877661-35234E3E-0CB2-421C-A065-6911E0953078 Q37947163-B10FF7BE-B9C9-45B0-9D1A-BC58ABB916D2 Q38710800-192F4074-C7E2-4EF2-84D0-17F3288DC4A5 Q38837036-85EAA698-A23E-4FDF-965E-972D2F3289B3 Q38838467-838323FB-05D7-4E72-806B-9DB0395E7951 Q47732542-356476BC-91FD-49ED-AA3D-296006B497F5 Q54377524-077ED80A-9AA4-4B49-AB38-F4C874C6D7E5

P2860

Cancer immunotherapy and nanomedicine.

http://www.wikidata.org/entity/Q37785836

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cancer immunotherapy and nanomedicine.

@en

Cancer immunotherapy and nanomedicine.

@nl

type

label

Cancer immunotherapy and nanomedicine.

@en

Cancer immunotherapy and nanomedicine.

@nl

prefLabel

Cancer immunotherapy and nanomedicine.

@en

Cancer immunotherapy and nanomedicine.

@nl

P1433

Q37785836-9F6BD8A0-EC71-4B3A-9672-1B480102B123

P1476

Q37785836-80DD3A81-E69C-44CF-9AF3-8C2775A91728

P2093

Q37785836-0EA0EFBD-9952-4027-AC4F-29E467C2C3AF

Q37785836-6ABD6A1F-9E65-4029-977A-2BF971EADD26

P2860

Q37785836-043423D6-908A-4A59-AAFE-789C24800E1F

Q37785836-082CDAFD-4BCF-4A1E-BE93-113E60F316B2

Q37785836-0C928DEC-1609-4469-B4F8-E585CAD94FD7

Q37785836-0DC76685-0E92-4CCC-90C3-D88A78975213

Q37785836-13597E27-A3B7-4B59-911A-25C5DFB1F7EA

Q37785836-15E03A62-55CF-4837-9796-B621693A9388

Q37785836-18391F03-6324-4C68-BBEA-630991398E13

Q37785836-1F97207F-3A8A-49AD-819C-30EF5F4BC1BF

Q37785836-22F56BAB-22D3-4199-B3F8-91E1CE0B683F

Q37785836-26929134-DD4D-4CDB-B6FC-5F7563A926BF

P304

Q37785836-F251BFF2-ABC2-499C-8D2E-DD834D3BC9E0

P31

Q37785836-BB01BFC0-799D-4114-AFE9-75238F2BEBD6

P356

Q37785836-DB2B31FD-6CC8-4F78-AC04-BC4873A8D62D

P433

Q37785836-1220A8C2-1AD6-482A-BBEE-A3A02212F35A

P478

Q37785836-0F4097B7-69BE-4C80-A5FF-DB456D6F1AA3

P577

Q37785836-BA2EFCC6-1C3B-4313-B591-FB54757EBDC7

P698

Q37785836-9E0E7343-E685-4B4A-AA0D-9B78552AA935

P921

Q37785836-F4F7699F-E0CD-4727-A342-A5FCE84DA905

P356

S11095-010-0258-8

P1433

Pharmaceutical Research

P1476

Cancer immunotherapy and nanomedicine.

@en

P2093

Leaf Huang

http://www.w3.org/2001/XMLSchema#string

Wei-Yun Sheng

http://www.w3.org/2001/XMLSchema#string

P2860

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Myeloid-derived suppressor cells as regulators of the immune system

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2

The three Es of cancer immunoediting

Calreticulin exposure dictates the immunogenicity of cancer cell death

P304

200-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-010-0258-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20821040

http://www.w3.org/2001/XMLSchema#string

P921